Predicting disease with big data
The monthly Bay Area Strategic Engagement Seminars (BASES) series in California has been, by all accounts, a home run. The series gives staff a chance to learn from leaders in key Sandia-related fields, and most recently brought Stanford University Genetics Chair Michael Snyder to campus.
Magnetic nanoparticles leap from lab bench to breast cancer clinical trials
Dale Huber has been working on the challenge of making iron-based nanoparticles the exact same size for 15 years. Now, the Sandia materials chemist and his long-term collaborators at Imagion Biosystems will use these magnetic nanoparticles for their first breast cancer clinical trial later this year.
Biologically inspired membrane purges most greenhouse gases from coal-fired smoke
Biologically inspired membrane purges most greenhouse gases from coal-fired smoke
The power of community boosts acequia resilience
The power of community boosts acequia resilience
Using biomimicry to detect outbreaks faster
Using biomimicry to detect outbreaks faster
Glowing designer sponges
A Sandia National Laboratories team has designed and synthesized nanoparticles that glow red and are stable, useful properties for tracking cancer growth and spread.
Researchers work on new way to image the brain
Sandia scientists have a simpler, less expensive way to accurately image the brain for diagnosing and studying neurological conditions
Infectious diseases: CTRL + ALT + Delete
Sandia joins gene editing safety project
